KEY FEATURES
| Full Name | Tumor Necrosis Factor Receptor Superfamily, Member 8 |
|---|---|
| Synonym | CD30; KI-1; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human TNFRSF8 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TNFRSF8. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TNFRSF8 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TNFRSF8, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TNFRSF8. You can calculate the concentration of Human TNFRSF8 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TNFRSF8 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.08 | 2.88 | 8.82 | 0.98 | 2.72 | 9.17 |
| Standard deviation | 0.06 | 0.17 | 0.42 | 0.07 | 0.12 | 0.32 |
| CV(%) | 5.23 | 5.82 | 4.79 | 6.95 | 4.38 | 3.51 |
RECOVERY
The recovery of Human TNFRSF8 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-108 | 100 |
| EDTA plasma (n=8) | 89-105 | 97 |
| Cell culture media (n=8) | 94-109 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TNFRSF8 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TNFRSF8 ELISA Kits
| CD4 ELISA Kit | publications with TNFRSF8 and CD4 |
| ALK ELISA Kit | publications with TNFRSF8 and ALK |
| CD5 ELISA Kit | publications with TNFRSF8 and CD5 |
| TNFSF8 ELISA Kit | publications with TNFRSF8 and TNFSF8 |
| TRAF2 ELISA Kit | publications with TNFRSF8 and TRAF2 |
| TRAF1 ELISA Kit | publications with TNFRSF8 and TRAF1 |
| ICAM1 ELISA Kit | publications with TNFRSF8 and ICAM1 |
| TRAF3 ELISA Kit | publications with TNFRSF8 and TRAF3 |
| TRAF5 ELISA Kit | publications with TNFRSF8 and TRAF5 |
| FUT4 ELISA Kit | publications with TNFRSF8 and FUT4 |
Pathways associated with TNFRSF8 ELISA Kit
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| TNF-alpha/NF-kB Signaling Pathway | TNF-alpha/NF-kB Signaling Pathway |
Diseases associated with TNFRSF8 ELISA Kit
| Hodgkin Disease | publications with TNFRSF8 and Hodgkin Disease |
| Necrosis | publications with TNFRSF8 and Necrosis |
| Inflammation | publications with TNFRSF8 and Inflammation |
| Cell Transformation, Neoplastic | publications with TNFRSF8 and Cell Transformation, Neoplastic |
| Fever | publications with TNFRSF8 and Fever |
| Hyperplasia | publications with TNFRSF8 and Hyperplasia |
| Neoplasm Metastasis | publications with TNFRSF8 and Neoplasm Metastasis |
| Disease Models, Animal | publications with TNFRSF8 and Disease Models, Animal |
| Liver Diseases | publications with TNFRSF8 and Liver Diseases |
| Kidney Diseases | publications with TNFRSF8 and Kidney Diseases |
Organs/Tissues associated with TNFRSF8 ELISA Kit
| Blood | publications with TNFRSF8 and Blood |
| Lymph Node | publications with TNFRSF8 and Lymph Node |
| Lung | publications with TNFRSF8 and Lung |
| Intestine | publications with TNFRSF8 and Intestine |
| Embryonic Tissue | publications with TNFRSF8 and Embryonic Tissue |
| Testis | publications with TNFRSF8 and Testis |
| Uterus | publications with TNFRSF8 and Uterus |
| Salivary Gland | publications with TNFRSF8 and Salivary Gland |